p16 Expression in Odontogenic Tumors

Regezi J.A. , Sciubba J.J. : Oral Pathology, 3rd ed, pp 323–356, WB Saunders, Philadelphia, 1999.

Kawamata N. , Morosetti R. , Miller C.W. , Park D. , Spirin K.S. , Nakamaki T. , Takeuchi S. , Hatta Y. , Simpson J. , Wilczynski S. , Lee Y.Y. , Bartram C.R. , Koeffler H.P. : Molecular analysis of the cyclin-dependent kinase inhibitor gene p27/Kip1 in human malignancies. Cancer Res, 55: 2266–2269, 1995.

Serrano M. , Hannon G.J. , Beach D. : A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature, 366: 704–707, 1993.

Xiong Y. , Hannon G.J. , Zhang H. , Casso D. , Kobayashi R. : Beach, p21 is a universal inhibitor of cyclin kinases. Nature, 366: 701–704, 1993.

Huang L. , Goodrow T.L. , Zhang S.Y. , Klein-Szanto A.J. , Chang H. , Ruggeri B.A. : Deletion and mutation analyses of the p16/MTS-1 tumor suppressor gene in human ductal pancreatic cancer reveals a higher frequency of abnormalities in tumor-derived cell lines than in primary ductal adenocarcinomas. Cancer Res, 56: 1137–1141, 1996.

Kamb A. , Gruis N.A. , Weaver-Feldhaus J. , Liu Q. , Harshman K. , Tavtigian S.V. , Stockert E. , Day R.S. , Johnson B.E. , Skolnick M.H. : A cell cycle regulator potentially involved in genesis of many tumor types. Science, 264: 436–440, 1994.

Lerma E. , Esteller M. , Herman J.G. , Prat J. : Alterations of the p16^INK4a/RB/ cyclin D1 pathway in vulvar carcinoma, vulvar intraepithelial neoplasia, and lichen sclerosus. Hum Pathol, 33: 1120–1125, 2002.

Grana X. , Reddy E.P. : Cell cycle control in mammalian cells: role of cyclins, cyclin dependent kinases (CDKs), growth suppressor genes and cyclin-dependent kinase inhibitors (CKIs). Oncogene, 11: 211–219, 1995.

Harper J.W. , Adami G.R. , Wei N. , Keyomarsi K. , Elledge S.J. : The p21 cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell, 75: 805–816, 1993.

Polyak K. , Lee M.H. , Erdjument-Bromage H. , Koff A. , Roberts J.M. , Tempst P. , Massague J. : Cloning of p27 Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell, 78: 59–66, 1994.

Serrano M. , Gomez-Lahoz E. , DePinho R.A. , Beach D. , Bar-Sagi D. : Inhibition of ras-induced proliferation and cellular transformation by p 16INK4. Science, 267: 249–252, 1995.

Toyoshima H. , Hunter T. : p27, a novel inhibitor of G1 cyclin-cdk protein kinase activity, is related to p21. Cell, 78: 67–74, 1994.

Ghiorzo P. , Villaggio B. , Sementa A.R. , Hansson J. , Platz A. , Nicolo G. , Spina B. , Canepa M. , Palmer J.M. , Hayward N.K. , Bianchi-Scarra G. : Expression and localization of mutant p16 proteins in melanocytic lesions from melanoma patients. Hum Pathol, 35: 25–33, 2004.

Kang Y.K. , Kim W.H. , Jang J.J. : Expression of G1-S modulators (p53, p16, p27, cyclin D1, R6) and SMAD4/Dpc4 in intra-hepatic cholangiocarcinoma. Hum Pathol, 33: 877–883, 2002.

Riethdorf L. , Riethdorf S. , Lee K.R. , Cviko A. , Loning T. , Crum C.P. : Human papillomaviruses, expression of p16^INK4A and early endocervical glandular neoplasia. Hum Pathol, 33: 899–904, 2002.

Handa K. , Yamakawa M. , Takeda H. , Kimura S. , Takahashi T. : Expression of cell cycle markers in colorectal carcinoma: superiority of cyclin A as an indicator of poor prognosis. Int J Cancer, 84: 225–233, 1999.

Hirabayashi S. : Immunohistochemical detection of DNA topoisomerase type IIa and Ki-67 in adenoid cystic carcinoma and pleomorphic adenoma of the salivary gland. J Oral Pathol Med, 28: 131–136, 1999.

Maeyama H. , Furuwatari C. , Ota H. , Akamatsu T. , Nakayama J. , Katsuyama T. : Histone H3 messenger RNA in situ hybridization for identifying proliferating cells in formalin-fixed rat gastric mucosa. Histochem J, 29: 867–873, 1997.

Yabuki N. , Sasano H. , Kato K. , Ohara S. , Toyota T. , Nagura H. , Miyaike M. , Nozaki N. , Kikuchi A. : Immunohistochemical study of DNA topoisomerase II in human gastric disorders. Am J Pathol, 149: 997–1007, 1996.

Donnellan R. , Chetty R. : Cyclin D1 and human neoplasia. Mol Pathol, 51: 1–7, 1998.

Jiang W. , Zhang Y.J. , Kahn S.M. , Hollstein M.C. , Santella R.M. , Lu S.H. , Harris C.C. , Montesano R. , Weinstein I.B. : Altered expression of the cyclin D1 and retinoblastoma genes in human esophageal cancer. Proc Natl Acad Sci USA, 90: 9026–9030, 1993.

Kudo Y. , Takata T. , Ogawa I. , Sato S. , Nikai H. : Expression of p53 and p21 CIP1/WAF1 proteins in oral epithelial dysplasias and squamous cell carcinomas. Oncol Rep, 6: 539–545, 1999.

Loda M. , Cukor B. , Tam S.W. , Lavin P. , Fiorentino M. , Draetta G.F. , Jessup J.M. , Pagano M. : Increased proteasome-dependent degradation of the cyclin-dependent kinase inhibitor p27 in aggressive colorectal carcinomas. Nat Med, 3: 231–234, 1997.

Moriya T. , Sakamoto K. , Sasano H. , Kawanaka M. , Sonoo H. , Manabe T. , Ito J. : Immunohistochemical analysis of Ki-67, p53, p21, and p27 in benign and malignant apocrine lesions of the breast: its correlation to histologic findings in 43 cases. Mod Pathol, 13: 13–18, 2000.

Pande P. , Mathur M. , Shukla N.K. , Ralhan R. : pRb and p16 protein alterations in human oral tumorigenesis. Eur J Cancer B Oral Oncol, 34: 396–403, 1998.

Sano T. , Hikino T. , Xue Q. , Saito T. , Kashiwabara K. , Oyama T. , Nakajima T. : Immuno-histochemical overexpression of p16 protein associated with intact retinoblastoma protein expression in cervical cancer and cervical intraepithelial neoplasia. Pathol Int, 48: 580–585, 1998.

Shoji M. , Dobashi Y. , Morinaga S. , Jiang S.X. , Kameya T. : Tumor extension and cell proliferation in adenocarcinomas of the lung. Am J Pathol, 154: 909–918, 1999.

van Oijen M.G. , Tilanus M.G. , Medema R.H. , Slootweg P.J. : Expression of p21 (Waf1/Cip1) in head and neck cancer in relation to proliferation, differentiation, p53 status and cyclin D1 expression. J Oral Pathol Med, 27: 367–375, 1998.

Herman J.G. , Civin C.I. , Issa J.P. , Collector M.I. , Sharkis S.J. , Baylin S.B. : Distinct patterns of inactivation of p15 and p16 characterize the major types of haematological malignancies. Cancer Res, 57: 837–841, 1997.

Liggett W.H. , Sidransky D. : Role of the p16 tumor suppressor gene in cancer. J Clin Oncol, 16: 1197–1206, 1998.

Kobayashi S. , Shirasawa H. , Sashiyama H. , Kawahira H. , Kaneko K. , Asano T. , Ochiai T. : p16 INK4a expression adenovirus vector to suppress pancreas cancer cell proliferation. Clin Cancer Res, 5: 4182–4185, 1999.

Okamoto A. , Demetrick D.J. , Spillare E.A. , Hagiwara K. , Hussain S.P. , Bennett W.P. , Forrester K. , Gerwin B. , Serrano M. , Beach D.H. , Harris C.C. : Mutations and altered expression of p16 INK4 in human cancer. Proc Natl Acad Sci USA, 91: 11045–11049, 1994.

Kumamoto H. , Kimi K. , Ooya H. : Detection of cell cycle-related factors in ameloblastomas. J Oral Pathol Med, 30: 309–315, 2001.

Schreiber M. , Muller W.J. , Singh G. , Graham F.L. : Comparison of the effectiveness of adenovirus vectors expressing cyclinkinase inhibitors p16 INK4a, p18 INK4c, p19 INK4d, p21 WAF1/CIP1 and p27 KIP1 in inducing cell cycle arrest, apoptosis and inhibition of tumorigenicity. Oncogene, 18: 1663–1676, 1999.

Hall M. , Peters G. : Genetic alterations of cyclins, cyclin-dependent kinases, and cdk inhibitors in human cancer. Adv Cancer Res, 68: 67–108, 1996.

Hunter T. , Pines J. : Cyclins and cancer. II: cyclin D and CDK inhibitors come of age. Cell, 79: 573–582, 1994.

Barnes L. , Eveson J.W. , Reichart P. , Sidransky D (Eds): Head and Neck Tumours, Pathology and Genetics, WHO Classification of Tumours. IARC Press, Lyon, 2005.

Merlo A. , Herman J.G. , Mao L. , Lee D.J. , Gabrielson E. , Burger P.C. , Baylin S.B. , Sidransky D. : 5’ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers. Nat Med, 1: 686–692, 1995.

Nobori T. , Miura K. , Wu D.J. , Lois A. , Takabayashi K. , Carson D.A. : Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers, Nature, 368: 753–756, 1994.

Okamoto A. , Hussain S.P. , Hagiwara K. , Spillare E.A. , Rusin M.R. , Demetrick D.J. , Serrano M. , Hannon G.J. , Shiseki M. , Zariwala M. : Mutations in the p16INK4/ MTS1/CDKN2, p15INK4B/ MTS2, and p18 genes in primary and metastatic lung cancer. Cancer Res, 55: 1448–1451, 1995.

Shintani S. , Mihara M. , Nakahara Y. : Infrequent alterations of RB pathway (Rb-p16 INK4A-cyclin D1) in adenoid cystic carcinoma of salivary glands. Anticancer Res, 20: 2169–2175, 2000.

Reed A.L. , Califano J. , Cairns P. , Weatra W.H. , Jones R.M. , Koch W. , Ahrendt S. , Eby Y. , Sewell D. , Nawroz H. , Bartek J. , Sidransky D. : High frequency of p16 inactivation in head and neck squamous cell carcinoma. Cancer Res, 56: 3630–3633, 1996.

Yuen P. , Man M. , Yin Lam K. , Lam Kwong Y. : Clinicopathologic significance of p16 gene expression in the surgical treatment of head and neck squamous cell carcinoma. J Clin Pathol, 55: 58–60, 2002.

Lang J.C. , Borchers J. , Danahey D. , Smith S. , Stover D.G. , Agrawal A. , Malone J.P. , Schuller D.E. , Weghorst C.M. , Holinga A.J. , Lingam K. , Patel C.R. , Esham B. : Mutational status or overex-pressed p16 in head and neck cancer: evidence for germline mutation of p16/p14 ARF. Int J Oncol, 21: 401–408, 2002.

Natarajan E. , Saeb M. , Crum C.P. , Woo S.B. , McKee P.H. , Rheinwald J.G. : Co-expression of p16 (INK4A) and laminin 5 gamma 2 by microinvasive and superficial squamous cell carcinomas in vivo and by migrating wound and senescent keratinocytes in culture. Am J Pathol, 163: 477–491, 2003.

Chen Q. , Luo G. , Li B. , Samaranayake L.P. : Expression of p16 and CDK4 in oral premalignant lesions and oral squamous cell carcinomas: a semiquantitative immunohistochemical study. J Oral Pathol Med, 28: 158–164, 1999.